Authors: Fiscella, RG Gaynes, BI Jensen, M

Citation: Rg. Fiscella et al., Equivalence of generic and brand-name ophthalmic products, AM J HEAL S, 58(7), 2001, pp. 616-617

Authors: Lee, DA Fechtner, RD Fiscella, RG Singh, K Stewart, WC

Citation: Da. Lee et al., Emerging perspectives on glaucoma: Highlights oil a roundtable discussion, AM J OPHTH, 130(4), 2000, pp. S1-S11

Authors: Skolnick, CA Fiscella, RG Tessler, HH Goldstein, DA

Citation: Ca. Skolnick et al., Tissue plasminogen activator to treat impending pupillary block glaucoma in patients with acute fibrinous HLA-B27 positive iridocyclitis, AM J OPHTH, 129(3), 2000, pp. 363-366

Authors: Messick, CR Pendland, SL Moshirfar, M Fiscella, RG Losnedahl, KJ Schriever, CA Schreckenberger, PC

Citation: Cr. Messick et al., In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitis, J ANTIMICRO, 44(2), 1999, pp. 297-298

Authors: Fiscella, RG Nguyen, TKP Cwik, MJ Phillpotts, BA Friedlander, SM Alter, DC Shapiro, MJ Blair, NP Gieser, JP

Citation: Rg. Fiscella et al., Aqueous and vitreous penetration of levofloxacin after oral administration, OPHTHALMOL, 106(12), 1999, pp. 2286-2290

Authors: Fiscella, RG Geller, JL Gryz, LL Wilensky, J Viana, M

Citation: Rg. Fiscella et al., Cost considerations of medical therapy for glaucoma, AM J OPHTH, 128(4), 1999, pp. 426-433